Company Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours.
The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
| Country | United States |
| Founded | 2000 |
| IPO Date | May 15, 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | Dr. James R. Hollingshead Ph.D. |
Contact Details
Address: 100 Nagog Park Acton, Massachusetts 01720 United States | |
| Phone | 978-600-7000 |
| Website | insulet.com |
Stock Details
| Ticker Symbol | PODD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001145197 |
| CUSIP Number | 45784P101 |
| ISIN Number | US45784P1012 |
| Employer ID | 04-3523891 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. James R. Hollingshead Ph.D. | President, Chief Executive Officer and Director |
| Shacey Petrovic | Director and Advisor |
| Eric Benjamin | Executive Vice President, Chief Product and Customer Experience Officer |
| Lauren Budden | Group Vice President, Chief Accounting Officer, Controller and Interim Chief Financial Officer and Treasurer |
| Prem Singh | Senior Vice President of Global Operations |
| Mark Field | Senior Vice President and Chief Technology Officer |
| Deborah R. Gordon CPA | Vice President of Investor Relations |
| John Wodick Kapples | Senior Vice President and General Counsel |
| Laetitia Cousin | Senior Vice President of Regulatory Affairs, Quality Assurance and Compliance |
| Angela Geryak Wiczek | Senior Director of Corporate Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 20, 2024 | 8-K | Current Report |
| Mar 1, 2024 | 8-K | Current Report |
| Feb 28, 2024 | 144 | Filing |
| Feb 23, 2024 | 10-K | Annual Report |
| Feb 22, 2024 | 8-K | Current Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |